← Evidence map

ArticleNeuro-oncology advances

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma.

Maria Vieito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
cites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36382109